Pinnacle Wealth Management Advisory Group LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 48.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,860 shares of the healthcare conglomerate’s stock after purchasing an additional 1,901 shares during the period. Pinnacle Wealth Management Advisory Group LLC’s holdings in UnitedHealth Group were worth $2,436,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the business. Integrated Wealth Concepts LLC raised its holdings in UnitedHealth Group by 12.2% in the second quarter. Integrated Wealth Concepts LLC now owns 33,206 shares of the healthcare conglomerate’s stock valued at $13,801,000 after acquiring an additional 3,608 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of UnitedHealth Group by 14.0% in the 2nd quarter. NewEdge Advisors LLC now owns 94,610 shares of the healthcare conglomerate’s stock valued at $39,322,000 after purchasing an additional 11,591 shares during the last quarter. Pointe Capital Management LLC lifted its position in shares of UnitedHealth Group by 16.0% during the 2nd quarter. Pointe Capital Management LLC now owns 1,595 shares of the healthcare conglomerate’s stock worth $663,000 after purchasing an additional 220 shares during the last quarter. Baird Financial Group Inc. grew its stake in shares of UnitedHealth Group by 41.6% during the second quarter. Baird Financial Group Inc. now owns 149,809 shares of the healthcare conglomerate’s stock worth $62,265,000 after purchasing an additional 44,042 shares in the last quarter. Finally, One Charles Private Wealth Services LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $268,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is owned by company insiders.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the previous year, the company posted $4.08 EPS. The company’s quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be issued a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 59.72%.
Analyst Ratings Changes
UNH has been the topic of several research analyst reports. Truist Financial raised their target price on UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Zacks Research upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 16th. Mizuho increased their target price on shares of UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research report on Monday, July 20th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $456.56.
View Our Latest Report on UnitedHealth Group
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.
UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
